APA (7th ed.) Citation

J, K., EM, G., CT, C., M, R., CC, T., K, M., . . . SH, P. (2011). Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer. Cancer (0008543X), 117(14), 3173. https://doi.org/10.1002/cncr.25786

Chicago Style (17th ed.) Citation

J, Kao, et al. "Phase 1 Trial of Concurrent Erlotinib, Celecoxib, and Reirradiation for Recurrent Head and Neck Cancer." Cancer (0008543X) 117, no. 14 (2011): 3173. https://doi.org/10.1002/cncr.25786.

MLA (9th ed.) Citation

J, Kao, et al. "Phase 1 Trial of Concurrent Erlotinib, Celecoxib, and Reirradiation for Recurrent Head and Neck Cancer." Cancer (0008543X), vol. 117, no. 14, 2011, p. 3173, https://doi.org/10.1002/cncr.25786.